• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDOS INTERNATIONAL SARL UNKENTERPRISE2; INTRACRANIAL NEUROVASCULAR STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDOS INTERNATIONAL SARL UNKENTERPRISE2; INTRACRANIAL NEUROVASCULAR STENT Back to Search Results
Catalog Number UNKENTERPRISE2
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Transient Ischemic Attack (2109); Thrombosis/Thrombus (4440)
Event Type  Injury  
Event Description
It was reported, via a personal interaction, that an unknown enterprise2 stent (product code/lot # unknown) was used for a stent-assisted coil embolization of a ruptured fusiform aneurysm at internal carotid artery and posterior cerebral artery.During the procedure, the user reported a stent-related ischemic complication developed and the patient¿s mrs decreased by more than 1.The event was reported as such, ¿the procedure was a stent-assisted coil embolization of a ruptured fusiform aneurysm at internal carotid artery and posterior cerebral artery.The enterprise 2 was implanted during the procedure.Stent-related ischemic complication developed and mrs decreased by more than 1.Detailed information on the post-procedure patient¿s condition was unobtainable.Continuous flush was unknown.The lesions were internal carotid artery and posterior cerebral artery.Other concomitant devices were unknown.¿ additional information was received on 23-apr-2024.Summary: regarding what the physician thinks may have caused or contributed to the event, it was commented, ¿ischemic complication was related to stent implantation.¿ regarding if the event occurred intra-procedurally, if the thrombus was flow limiting, the location of the thrombus in relation to the location of the enterprise2 stent, the patient¿s baseline neurological status, how the event was treated, and if symptoms were persistent, were all unobtainable information.No further information was made available.
 
Manufacturer Narrative
Product complaint (b)(4) information regarding patient weight, height, medical history, race, and ethnicity was not reported.B.3 ¿ date of event: the date of the event was not reported.D.4: the product catalog and lot numbers are not available / not reported.The unique identifier (udi) and expiration date of the device is not known.Section e.1: initial reporter: the customer contact information, including name, occupation, phone, fax, and e-mail address, was not reported.H.4: the device manufacture date is not known as the device lot number is not available / not reported.The device remains implanted; therefore, no further investigation can be performed.The lot number is not known; therefore, a device history record review cannot be completed.Stent thrombosis resulting in ischemia is a known potential complication associated with the enterprise2 stent and is mentioned in the instructions for use (ifu) as such.There were no alleged quality issues related to the used device, as the device performed as intended.The modified rankin scale (mrs) measures the degree of disability/dependence after a stroke.Since the patient¿s (b)(6) decreased by ¿more than 1,¿ this event does meet the criteria of a serious injury.Therefore, this event does meet us fda reporting criteria under 21 cfr 803 with a classification of ¿serious injury.¿ the file will be re-reviewed if additional information is received at a later date.As part of the post market surveillance program, information from this complaint is trended to identify statistical signals for consideration of further correction action.Since there was no evidence to suggest the event was related to a manufacturing or design issue, no corrective actions will be taken at this time.This report is being submitted pursuant to the provisions of 21 cfr, part 803 (and/or part 4, as applicable).This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by cerenovus, or its employees that the report constitutes an admission that the product, cerenovus, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
UNKENTERPRISE2
Type of Device
INTRACRANIAL NEUROVASCULAR STENT
Manufacturer (Section D)
MEDOS INTERNATIONAL SARL
chemin-blanc 38
le locle neuchatel CH-24 00
SZ  CH-2400
Manufacturer (Section G)
CERENOVUS INC
325 paramount dr
raynham MA 02767
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
3035526892
MDR Report Key19191476
MDR Text Key341145188
Report Number3008114965-2024-00433
Device Sequence Number1
Product Code NJE
Combination Product (y/n)N
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional
Reporter Occupation Other
Type of Report Initial
Report Date 04/26/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNKENTERPRISE2
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 04/10/2024
Initial Date FDA Received04/26/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening;
Patient Age89 YR
Patient SexFemale
-
-